investorscraft@gmail.com

Stock Analysis & ValuationYD Bio Limited Ordinary Shares (YDES)

Previous Close
$11.87
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

No. 3, Xingnan St.
Taipei 115001
TW
Industry: Biotechnology
Sector: Healthcare
CEO: Ethan Shen
Full Time Employees: 4

Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.

HomeMenuAccount